Kampala, Uganda | THE INDEPENDENT | Leading drug manufacturing firms, Sanofi and GlaxoSmithKline, have entered into an agreement to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. …
Read More »BAT joins race to develop COVID-19 vaccine
Kampala, Uganda | THE INDEPENDENT | British American Tobacco (BAT) US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing. If testing goes well, BAT is hopeful that with the right partners and support from government agencies, between 1 and 3 …
Read More »